Subretinal Fibrosis in HARBOR Varies by Choroidal Neovascularization Subtype

Ophthalmol Retina. 2020 Jul;4(7):752-754. doi: 10.1016/j.oret.2020.02.012. Epub 2020 Feb 27.

Authors

Sean D Adrean¹, Elizabeth Morgenthien², Avanti Ghanekar², Ferhina S Ali³

Affiliations

¹ Retina Consultants of Orange County, Fullerton, California. Electronic address: seadrean@yahoo.com.
² Genentech, Inc., South San Francisco, California.
³ Genentech, Inc., South San Francisco, California; Retina Center of Texas, Dallas, Texas.

PMID: 32414568
DOI: 10.1016/j.oret.2020.02.012

No abstract available

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Angiogenesis Inhibitors / administration & dosage
Choroid / pathology*
Choroidal Neovascularization / diagnosis*
Choroidal Neovascularization / drug therapy
Female
Fibrosis / diagnosis
Fibrosis / etiology*
Fluorescein Angiography / methods*
Fundus Oculi
Humans
Intravitreal Injections
Male
Ranibizumab / administration & dosage*
Retina / pathology*
Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

Angiogenesis Inhibitors
Vascular Endothelial Growth Factor A
Ranibizumab